Physicians' opinions about decision aids for patients considering systemic adjuvant therapy for axillary-node negative breast cancer

Patient Education and Counseling

Volumn 30, Issue 2, 1997, Pages 143-153

  O'Connor, A M ^a   Llewellyn Thomas, H A ^b   Sawka, C ^c   Pinfold, S P ^b   To, T ^b   Harrison, D E ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c Ontario Cancer Treatment and Research Foundation   (Canada)

Author keywords

decision making; oncology; patient education

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST CANCER; DECISION MAKING; DOCTOR PATIENT RELATION; EDUCATION; FEMALE; HUMAN; PATIENT INFORMATION; PHYSICIAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; AXILLA; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; PATIENT EDUCATION; PHYSICIANS; QUESTIONNAIRES;

EID: 0031081729     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-3991(96)00948-2     Document Type: Article

References (30)

1. [1] Henderson IC. Adjuvant systemic therapy of early breast cancer. In: Harris J, Hellman S, Henderson IC, editors. Breast disease, 2nd ed. Philadelphia, PA: J.B. Lippincott, 1991; 427-486.
2. [2] Early Breast Cancer Trialists' Collaborative Group. Systemic treatment for early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339: 71-85.
3. [3] Balneaves L, Kristjanson L. Breast cancer and communication: an annotated bibliography. National Breast Cancer Forum, 1994.
4. [4] Degner LS, Sloan GA. Decision making during serious illness: what role do patients really want to play? J Clin Epi 1992; 45: 941-950.
5. [5] Greene B. Breast Cancer: unanswered questions. Report of the Standing Committee on Health and Welfare, Social Affairs, Senior and the Status of Women. Subcommittee on the Status of Women, Fourth Report to the House, Ottawa: Supply and Services Canada Issue 9, 1992.
6. [6] Neufeld K, Degner L, Dick J. A nursing intervention to foster patient involvement in treatment decisions. Oncol Nurs Forum 1993; 20: 631-635.
7. [7] Vandenberg T, Gustafson D. CHESS Project - A randomized piolot study to evaluate the effect of computers on the quality of life and psychological status of patients with newly diagnosed breast cancer. St. Joseph's Health Centre, London Regional Cancer Centre, London, Ontario, Canada.
8. [8] Levine MN, Gafni A, Markham B, MacFarlane D. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med 1992; 117: 53-58.
9. [9] Sebban C, Browman G, Gafni A, Norman G, Levine M, Assouline D, Fiere D. Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogeneic bone marrow transplantation in chronic myeloid leukemia. Am J Hematol 1995; 48: 221-227.
10. [10] Barry MJ, Fowler FJ, Mulley AG, Henderson JV, Wennberg JE. Patient reactions to a program to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care 1995; 33: 771-782.
11. [11] O'Connor A, Tugwell P, Wells G, Elmslie T. Do decision aids help post-menopausal women considering preventive hormone replacement therapy [abstract]. Med Decis Making 1995; 15: 433.
12. [12] Kroll JC, Rothert ML, Rovner DR, Holmes-Rovner M, Schmitt N, Padonu GB, Talarczyk G, Breer ML. Decision support intervention: More is not necessarily better [abstract]. Med Decis Making 1994; 14(4): 440.
13. [13] O'Connor AM, Pennie RA, Dales RE. Framing effects on expectations, decisions and side effects experienced: the case of influenza immunization. J Clin Epi 1996; 49.
14. [14] Llewellyn-Thomas HA, McGreal MJ, Thiel Fine S, Erlichman C. Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 1991; 32: 35-42.
15. [15] Wolfe SD, Llewellyn-Thomas HA. Assessing in vitro fertilization preferences: trading off risks and benefits [abstract]. Med Decis Making 1991; 11: 322.
16. [16] Llewellyn-Thomas HA, Thiel EC, Naylor CD. Waiting for elective CABG: patients' perceived risks and utilities for time [abstract]. Med Decis Making 1992; 12: 337.
17. [17] Percy ML, Llewellyn-Thomas HA. Assessing preferences about the DNR order: does it depend on how you ask? [abstract]. Med Decis Making 1992; 12: 338.
18. [18] Sutherland HJ, Llewellyn-Thomas HA, Lockwood GA, Trichler DL. Cancer patients: their desire for information and participation in treatment decisions. J R Soc Med 1989; 82: 260-263.
19. [19] Siminoff LA, Petting JH, Ableoff MD. Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol 1989; 7: 1192-1200.
20. [20] Siminoff LA, Fetting JH. Factors affecting treatment decisions for a life-threatening illness: the case of medical treatment of breast cancer. Soc Sci Med 1991; 32: 813-818.
21. [21] Hughes KK. Decision-making by breast cancer patients: the role of information and treatment selection. Oncol Nurs Forum 1993; 20: 623-628.
22. [22] Pitz GF, Sachs NJ. Judgement and decision: theory and application. Annu Rev Psychol 1984; 35: 139-163.
23. [23] O'Connor AM. Decisional conflict. In: McFarland GK McFarlane EA, editors. Nursing diagnosis and intervention. Toronto, Ontario: C.V. Mosby Company, 1992.
24. [24] O'Connor A. Validation of a decisional conflict scale. Med Decis Making 1995; 15: 25-30.
25. [25] Morris J, Royle GT. Offering patients a choice of surgery for early breast cancer: a reduction in anxiety and depression in patients and their husbands. Soc Sci Med 1988; 26: 583-585.
26. [26] Fallowfield LJ, Hall A, Maguire GP, Baum M. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. Br Med J 1990; 301: 575-580.
27. [27] Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy - Part 1. Lancet 1992; 339: 1-15.
28. [28] Sawka CA, O'Connor AM, Llewellyn-Thomas HA, To T, Pinfold SP, Harrison-Woermke D. The appropriateness of adjuvant systemic therapy for axillary node-negative breast cancer: a physician opinion survey. J Clin Oncol 1995; 13: 1459-1469.
29. [29] Dillman DA, Mail and telephone surveys: total design method. New York: John Wiley and Sons, 1978.
30. [30] STATA version 3.0, 1992 Computing Resource Center, Santa Monica CA, USA.